Glycemic Metrics and Patterns in People With and Without Prediabetes
ConditionPre Diabetes
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAbbott Diabetes Care
About this trial
The FreeStyle Libre 3 Continuous Glucose Monitoring (FSL3) System is used to characterize the glycemic profiles of people with and without a prediabetes diagnosis.
Eligibility criteria
Qualifiers
Subject must be at least 18 years of age.
Subject must be willing and able to provide written signed and dated informed consent.
Disqualifiers
Subject has a diagnosis of type 1 diabetes, type 2 diabetes, or gestational diabetes.
Subject is known to be currently practicing a low-carbohydrate or ketogenic diet at the time of enrollment.
Subject is known to be pregnant at the time of enrollment.
Subject has known allergy to medical grade adhesive, isopropyl alcohol and/or ethyl alcohol used to disinfect skin.
Trial design
Treatments tested in this trial
- FreeStyle Libre 3
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov